[PATHOPHYSIOLOGICAL AND CLINICAL SIGNIFICANCE OF IL-31 IN ALLERGIC DISEASES].

PubMed 2026

View at publisher
Authors: Saeko Nakajima
DOI: 10.15036/arerugi.75.22
Cited by: 0

Fields of Study & Subjects

Dermatology and Skin Diseases Asthma and respiratory diseases IL-33 ST2 and ILC Pathways

Publication details

Journal / source
PubMed
Volume
75
Issue
1
Pages
22–26
Publication date
1 January 2026
Language
JA